<DOC>
	<DOC>NCT00445315</DOC>
	<brief_summary>Assess the safety, tolerability and pharmacokinetics of multiple oral doses of PF-00868554 in HCV positive patient volunteers</brief_summary>
	<brief_title>A Phase 1 Study Of PF-00868554 In Hepatitis C Virus (HCV) Positive Patients</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<criteria>HCV RNA â‰¥ 100,000 IU/mL at screening Genotype 1a or 1b Current or prior treatment with IFN and/or RBV Evidence of decompensated liver disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>